Cranbrook Wealth Management’s Abbott ABT Stock Holding History

Cranbrook Wealth Management’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$918K	Sell	10,122 -1,295	-11%	-$118K	0.17%	69
2026 Q1	$1.17M	Sell	11,417 -900	-7%	-$102K	0.24%	58
2025 Q4	$1.54M	Buy	12,317 +10	+0.1%	+$1.27K	0.3%	52
2025 Q3	$1.65M	Sell	12,307 -220	-2%	-$28.9K	0.33%	49
2025 Q2	$1.7M	Buy	12,527 +1,342	+12%	+$177K	0.36%	45
2025 Q1	$1.48M	Sell	11,185 -2,175	-16%	-$277K	0.34%	48
2024 Q4	$1.51M	Buy	13,360 +207	+2%	+$23.9K	0.35%	47
2024 Q3	$1.5M	Buy	13,153 +9,183	+231%	+$1.01M	0.34%	48
2024 Q2	$413K	Hold	3,970	–	–	0.1%	80
2024 Q1	$451K	Hold	3,970	–	–	0.11%	71
2023 Q4	$437K	Hold	3,970	–	–	0.12%	69
2023 Q3	$384K	Hold	3,970	–	–	0.11%	68
2023 Q2	$433K	Hold	3,970	–	–	0.12%	69
2023 Q1	$402K	Sell	3,970 -22	-0.6%	-$2.32K	0.11%	73
2022 Q4	$438K	Hold	3,992	–	–	0.12%	70
2022 Q3	$386K	Hold	3,992	–	–	0.1%	75
2022 Q2	$434K	Hold	3,992	–	–	0.11%	76
2022 Q1	$473K	Hold	3,992	–	–	0.1%	79
2021 Q4	$562K	Hold	3,992	–	–	0.12%	76
2021 Q3	$472K	Buy	3,992 +117	+3%	+$14.4K	0.11%	78
2021 Q2	$449K	Sell	3,875 -126	-3%	-$14.7K	0.1%	77
2021 Q1	$479K	Buy	4,001 +126	+3%	+$14.9K	0.12%	71
2020 Q4	$424K	Hold	3,875	–	–	0.11%	69
2020 Q3	$422K	Hold	3,875	–	–	0.12%	65
2020 Q2	$354K	Hold	3,875	–	–	0.11%	70
2020 Q1	$306K	Hold	3,875	–	–	0.1%	69
2019 Q4	$337K	Sell	3,875 -265	-6%	-$22.2K	0.09%	71
2019 Q3	$346K	Buy	4,140 +265	+7%	+$22.5K	0.1%	71
2019 Q2	$326K	Hold	3,875	–	–	0.09%	70
2019 Q1	$310K	Hold	3,875	–	–	0.1%	68
2018 Q4	$280K	Buy	3,875 +3,295	+568%	+$232K	0.1%	66
2018 Q3	$43K	Hold	580	–	–	0.02%	125
2018 Q2	$35K	Hold	580	–	–	0.01%	133
2018 Q1	$35K	Hold	580	–	–	0.01%	133
2017 Q4	$33K	Hold	580	–	–	0.01%	136
2017 Q3	$31K	Hold	580	–	–	0.01%	137
2017 Q2	$28K	Hold	580	–	–	0.01%	143
2017 Q1	$26K	Hold	580	–	–	0.01%	137
2016 Q4	$22K	Hold	580	–	–	0.01%	147
2016 Q3	$25K	Buy	+580	New	+$24.9K	0.01%	133
2016 Q2	–	Sell	-580	Closed	-$24K	–	191
2016 Q1	$24K	Hold	580	–	–	0.01%	128
2015 Q4	$26K	Hold	580	–	–	0.01%	125
2015 Q3	$23K	Hold	580	–	–	0.01%	131
2015 Q2	$28K	Hold	580	–	–	0.02%	130
2015 Q1	$27K	Hold	580	–	–	0.02%	130
2014 Q4	$26K	Hold	580	–	–	0.02%	130
2014 Q3	$24K	Hold	580	–	–	0.02%	106
2014 Q2	$24K	Hold	580	–	–	0.02%	105
2014 Q1	$22K	Hold	580	–	–	0.02%	104
2013 Q4	$22K	Buy	+580	New	+$21.4K	0.02%	132

Other funds holding ABT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Cranbrook Wealth Management's ABT Position: Q2 2026 in Review

Cranbrook Wealth Management reduced its Abbott (ABT) stake by 11% in Q2 2026, selling an estimated $118K and leaving 10,122 shares worth $918K. The position accounts for 0.17% of the portfolio, ranked #69.

Cranbrook Wealth Management first reported a position in ABT in Q4 2013 and has held it in 50 quarters since. The position peaked at $1.7M in Q2 2025. 2,964 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

Cranbrook Wealth Management held 10,122 shares of Abbott worth $918K as of Q2 2026.
Cranbrook Wealth Management sold 1,295 Abbott shares in Q2 2026, an estimated $118K.
Abbott made up 0.17% of Cranbrook Wealth Management's portfolio in Q2 2026, its #69 holding.
Cranbrook Wealth Management first reported a position in Abbott in Q4 2013 and has held it in 50 quarters since.
Cranbrook Wealth Management's Abbott position peaked at $1.7M in Q2 2025.
2,964 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Cranbrook Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.